Methadone for chronic non-cancer pain in adults

Cochrane Database of Systematic Reviews

Volumn 2017, Issue 8, 2012, Pages

  Haroutounian, Simon ^a   Mcnicol, Ewan D ^b   Lipman, Arthur G ^c  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TUFTS MEDICAL CENTER   (United States)

^c UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FENTANYL; METHADONE; MORPHINE; OXYCODONE; NARCOTIC ANALGESIC AGENT;

ANALGESIA; BACKACHE; CHRONIC PAIN; CONSTIPATION; DIZZINESS; DROWSINESS; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; HUMAN; INCIDENCE; LOSS OF APPETITE; MAINTENANCE THERAPY; NAUSEA; NEUROPATHIC PAIN; PAIN INTENSITY; PATIENT PREFERENCE; POSTHERPETIC NEURALGIA; PRIORITY JOURNAL; PRURITUS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; TREATMENT DURATION; TREATMENT RESPONSE; TREATMENT WITHDRAWAL; VOMITING; ADULT; META ANALYSIS; NEURALGIA;

ADULT; ANALGESICS, OPIOID; CHRONIC PAIN; HUMANS; METHADONE; NEURALGIA; NEURALGIA, POSTHERPETIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84872203958     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD008025.pub2     Document Type: Review

References (78)

1. Morley JS, Bridson J, Nash TP, Miles JB, White S, Makin MK. Low-dose methadone has an analgesic effect in neuropathic pain: a double-blind randomized controlled crossover trial. Palliative Medicine 2003;17:576-87. 3318990
2. Quang-Cantagrel ND, Wallace MS, Magnuson SK. Opioid substitution to improve the effectiveness of chronic noncancer pain control: a chart review. Anesthesia and Analgesia 2000;90:933-7. 3318992
3. Raja SN, Haythornthwaite JA, Pappagallo M, Clark MR, Travison TG, Sabeen S, et al. Opioids versus antidepressants in postherpetic neuralgia: a randomized, placebo-controlled trial. Neurology 2002;59:1015-21. 3318994
4. Altier N, Dion D, Boulanger A, Choiniere M. Successful use of methadone in the treatment of chronic neuropathic pain arising from burn injuries: a case-study. Burns 2001;27:771-5. 3318996
5. Altier N, Dion D, Boulanger A, Choiniere M. Management of chronic neuropathic pain with methadone: a review of 13 cases. Clinical Journal of Pain 2005;21:364-9. 3318998
6. Arnaert AC, Ciccotosto G. Response phases in methadone treatment for chronic nonmalignant pain. Pain Management Nursing 2006;7:23-30. 3319000
7. Arner S, Meyerson BA. Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain. Pain 1988;33:11-23. 3319002
8. Beaver WT, Wallenstein SL, Houde RW, Rogers A. A clinical comparison of the analgesic effects of methadone and morphine administered intramuscularly, and of orally and parenterally administered methadone. Clinical Pharmacology & Therapeutics 1967;8:415-26. 3319004
9. Bendiksen A, McGehee E, Handberg G. Methadone in the treatment of chronic non-malignant pain [Metadon til behandlingaf kroniske ikkemaligne smerter]. Ugeskrift for Laeger 2007;169:1568-72. 3319006
10. Berken GH, Stone MM, Stone SK. Methadone: an effective agent in managing intractable pain as a symptom of psychotic anger. Annals of the New York Academy of Sciences 1982;398:83-6. 3319008
11. Bouckoms AJ, Masand P, Murray GB, Cassem EH, Stern TA, Tesar GE. Chronic nonmalignant pain treated with long-term oral narcotic analgesics. Annals of Clinical Psychiatry 1992;4:185-92. 3319010
12. Byas-Smith MG, Chapman SL, Reed B, Cotsonis G. The effect of opioids on driving and psychomotor performance in patients with chronic pain. Clinical Journal of Pain 2005;21:345-52. 3319012
13. Byrne A. Opioids in chronic non-malignant pain. Don't forget methadone for chronic pain. BMJ 2001;323:572. 3319014
14. Cruciani RA, Sekine R, Homel P, Lussier D, Yap Y, Suzuki Y, et al. Measurement of QTc in patients receiving chronic methadone therapy. Journal of Pain and Symptom Management 2005;29:385-91. 3319016
15. Flavell Matts SG, Swan CH, Wharton BA. Double blind trial of dextromoramide, methadone and pethidine in the treatment of severe pain. Postgraduate Medical Journal 1964;40:103-5. 3319018
16. Fowle AS, Letley E. A comparison of diamorphine-with-cocaine and methadone. British Journal of Clinical Pharmacology 1978;5:527-8. 3319020
17. France RD, Urban BJ, Keefe FJ. Long-term use of narcotic analgesics in chronic pain. Social Science and Medicine 1984;19:1379-82. 3319022
18. Fredheim OMS, Kaasa S, Dale O, Klepstad P, Landrø NI, Borchgrevink PC. Opioid switching from oral slow release morphine to oral methadone may improve pain control in chronic non-malignant pain: a nine-month follow-up study. Palliative Medicine 2006;20:35-41. 3319024
19. Fredheim OMS, Borchgrevink PC, Klepstad P, Kaasa S, Dale O. Long term methadone for chronic pain: a pilot study of pharmacokinetic aspects. European Journal of Pain 2007;11:599-604. 3319026
20. Gagnon BA, Almahrezi A, Schreier G. Methadone in the treatment of neuropathic pain. Pain Research & Management 2003;8:149-54. 3319028
21. Gallagher RM, Welz-Bosna M, Gammaitoni A. Assessment of dosing frequency of sustained-release opioid preparations in patients with chronic nonmalignant pain. Pain Medicine 2007;8:71-4. 3319030
22. Gardner-Nix JS. Oral methadone for managing chronic nonmalignant pain. Journal of Pain and Symptom Management 1996;11:321-8. 3319032
23. Green J, Hickey S, Ansbacher S, Kartsonis P. Methadone use in a small series of selected patients with chronic nonmalignant pain. Pain Digest 1996;6:3-6. 3319034
24. Haythornthwaite JA, Menefee LA, Quatrano-Piacentini AL, Pappagallo M. Outcome of chronic opioid therapy for non-cancer pain. Journal of Pain and Symptom Management 1998;15:185-94. 3319036
25. Krebs EEB, Becker WC, Zerzan J, Bair MJ, McCoy K, Hui S. Comparative mortality among Department of Veterans Affairs patients prescribed methadone or long-acting morphine for chronic pain. Pain 2011;152:1789-95. 3319038
26. Lockwood AH. Daily scheduled opioids for intractable head pain: Long-term observations of a treatment program. Neurology 2004;63:2459. 3319040
27. Manchikanti L, Manchukonda R, Pampati V, Damron KS. Evaluation of abuse of prescription and illicit drugs in chronic pain patients receiving short-acting (hydrocodone) or long-acting (methadone) opioids. Pain Physician 2005;8:257-61. 3319042
28. Manchikanti L, Manchikanti KN, Pampati V, Cash KA. Prevalence of side effects of prolonged low or moderate dose opioid therapy with concomitant benzodiazepine and/or antidepressant therapy in chronic non-cancer pain. Pain Physician 2009;12:259-67. 3319044
29. McNulty JP. Chronic pain: levorphanol, methadone, and the N-methyl-D-aspartate receptor. Journal of Palliative Medicine 2009;12:765-6. 3319046
30. Mironer YE, Haasis JC III, Chapple IT, Somerville JJ, Barsanti JM. Successful use of methadone in neuropathic pain:a multicenter study by the National Forum of Independent Pain Clinicians. Pain Digest 1999;9:191-3. 3319048
31. Morley JS, Watt JW, Wells JC, Miles JB, Finnegan MJ, Leng G. Methadone in pain uncontrolled by morphine. Lancet 1993;342:1243. 3319050
32. Moulin DE, Palma D, Watling C, Schulz V. Methadone in the management of intractable neuropathic noncancer pain. Canadian Journal of Neurological Sciences 2005;32:340-3. 3319052
33. Naliboff BDW, Wu SM, Schieffer B, Bolus R, Pham Q, Baria A, et al. A randomized trial of 2 prescription strategies for opioid treatment of chronic nonmalignant pain. Journal of Pain 2011;12:288-96. 3319054
34. Peng PT, Tumber P, Stafford M, Gourlay D, Wong P, Galonski M, et al. Experience of methadone therapy in 100 consecutive chronic pain patients in a multidisciplinary pain center. Pain Medicine 2008;9:786-94. 3319056
35. Robbins L. Daily opioids (methadone) for refractory chronic daily headache. Headache Quarterly 1996;7:39-42. 3319058
36. Robbins L. Long-acting opioids (methadone) for refractory chronic daily headache:Quality of life assessment. Headache Quarterly 1997;8:234-6. 3319060
37. Robbins L. Long-acting opioids for severe chronic daily headache. Headache Quarterly 1999;10:135-40. 3319062
38. Robbins L. Long-acting opioids for refractory chronic migraine. Practical Pain Management 2009;July/August:45-54. 3319064
39. Rothrock JF. Management of chronic daily headache utilizing a uniform treatment pathway. Headache 1999;39:650-3. 3319066
40. Saper JR, Lake AE III, Hamel RL, Lutz TE, Branca B, Sims DB, et al. Daily scheduled opioids for intractable head pain. Long-term observations of a treatment program. Neurology 2004;62:1687-94. 3319068
41. Schofferman J. Long-term opioid analgesic therapy for severe refractory lumbar spine pain. The Clinical Journal of Pain 1999;15:136-40. 3319070
42. Shir Y, Rosen G, Zeldin A, Davidson EM. Methadone is safe for treating hospitalized patients with severe pain. Canadian Journal of Anaesthesia 2001;48:1109-13. 3319072
43. Sjøgren P, Thomsen AB, Olsen AK. Impaired neuropsychological performance in chronic nonmalignant pain patients receiving long-term oral opioid therapy. Journal of Pain and Symptom Management 2000;19:100-8. 3319074
44. Sprenger T, Seifert CL, Miederer M, Valet M, Tolle TR. Successful prophylactic treatment of chronic cluster headache with low-dose levomethadone. Journal of Neurology 2008;255:1832-3. 3319076
45. Taylor WF, Finkel AG, Robertson KR, Anderson AC, Toomey TC, Abashian SA, et al. Methadone in the treatment of chronic nonmalignant pain: a 2-year follow-up. Pain Medicine 2000;1:254-9. 3319078
46. Urban BJ, France RD, Steinberger EK, Scott DL, Maltbie AA. Long-term use of narcotic/antidepressant medication in the management of phantom limb pain. Pain 1986;24:191-6. 3319080
47. Walmsley R, Robson P, Lee MA. Use of methadone for uncontrolled pain: an alternative dosing regimen. Journal of Pain and Symptom Management 2010;40:e3-4. 3319082
48. Watson CPN, Watt-Watson J, Chipman M. The long-term safety and efficacy of opioids: a survey of 84 selected patients with intractable chronic noncancer pain. Pain Research and Management 2010;15:213-7. 3319084
49. Webster LR, Choi Y, Desai H, Webster L, Grant BJB. Sleep-disordered breathing and chronic opioid therapy. Pain Medicine 2008;9:425-32. 3319086
50. Blyth FM, March LM, Nicholas MK, Cousins MJ. Chronic pain, work performance and litigation. Pain 2003;103:41-7.
51. Breivik H, Collett B, Ventafridda V, Cohen R, Gallacher D. Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. European Journal of Pain 2006;10:287-333.
52. Centers for Disease Control and Prevention. Prescription painkiller overdoses: use and abuse of methadone as a painkiller. http://www.cdc.gov/vitalsigns/MethadoneOverdoses/index.html (accessed 16 July 2012).
53. Chou R, Fanciullo GJ, Fine PG, Adler JA, Ballantyne JC, Davies P, et al. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. Journal of Pain 2009;10:113-30.
54. Chugh SS, Socoteanu C, Reinier K, Waltz J, Jui J, Gunson K. A community-based evaluation of sudden death associated with therapeutic levels of methadone. American Journal of Medicine 2008;121:66-71.
55. Deeks JJ, Higgins JPT, Altman DG. Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JPT, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions. 5.0. Chichester: John Wiley & Sons, 2008:243-96.
56. Eisenberg E, McNicol E, Carr DB. Opioids for neuropathic pain. Cochrane Database of Systematic Reviews 2006, Issue 3. [DOI: 10.1002/14651858.CD006146]
57. Elbourne DR, Altman DG, Higgins JPT, Curtin F, Worthington HV, Vail A. Meta-analysis involving cross-over trials: methodological issues. International Journal of Epidemiology 2002;31:140-9.
58. Fredheim OM, Kaasa S, Fayers P, Saltnes T, Jordhoy M, Borchgrevink PC. Chronic non-malignant pain patients report as poor health-related quality of life as palliative cancer patients. Acta Anaesthesiologica Scandinavica 2008;52:143-8.
59. Furlan AD, Sandoval JA, Mailis-Gagnon A, Tunks E. Opioids for chronic noncancer pain: a meta-analysis of effectiveness and side effects. Canadian Medical Association Journal 2006;174:1589-94.
60. Longe JL, editor. The Gale Encyclopedia of Medicine. 3rd Edition. Thomson Gale, 1996.
61. Harstall C, Ospina M. How prevalent is chronic pain?. Pain: Clinical Updates 2003;11(2):1-4.
62. Kalso E, Edwards JE, Moore RA, McQuay HJ. Opioids in chronic non-cancer pain: systematic review of efficacy and safety. Pain 2004;112:372-80.
63. Krantz MJ, Martin J, Stimmel B, Mehta D, Haigney MC. QTc interval screening in methadone treatment. Annals of Internal Medicine 2009;150:378-95.
64. Manchikanti L, Singh A. Therapeutic opioids: a ten-year perspective on the complexities and complications of the escalating use, abuse, and nonmedical use of opioids. Pain Physician 2008;11:S63-88.
65. Manchikanti LA, Ailinani H, Koyyalagunta D, Datta S, Singh V, Eriator I, et al. A systematic review of randomized trials of long-term opioid management for chronic non-cancer pain. Pain Physician 2011;14:91-121.
66. McNicol E. Opioid side effects and their treatment in patients with chronic cancer and noncancer pain. Journal of Pain & Palliative Care Pharmacotherapy 2008;22:270-81.
67. Moore RA, Gavaghan D, Tramèr MR, Collins SL, McQuay HJ. Size is everything - large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects. Pain 1998;7:209-16.
68. Moore RA, Moore OA, Derry S, Peloso PM, Gammaitoni AR, Wang H. Responder analysis for pain relief and numbers needed to treat in a meta-analysis of etoricoxib osteoarthritis trials: bridging a gap between clinical trials and clinical practice. Annals of the Rheumatic Diseases 2010;69:374-9.
69. Moore RA, Eccleston C, Derry S, Wiffen P, Bell RF, Straube S, et al. ""Evidence" in chronic pain - establishing best practice in the reporting of systematic reviews. Pain 2010;150:386-9.
70. Moore RA, Straube S, Eccleston C, Derry S, Aldington D, Wiffen P, et al. Estimate at your peril: Imputation methods for patient withdrawal can bias efficacy outcomes in chronic pain trials using responder analyses. Pain 2012;153:265-8.
71. National Academies of Science and Institute of Medicine. Musculoskeletal disorders and the workplace: Low back pain and upper extremities. National Academies Press, 2001.
72. Nicholson AB. Methadone for cancer pain. Cochrane Database of Systematic Reviews 2007, Issue 4. [DOI: 10.1002/14651858.CD003971]
73. Nüesch E, Trelle S, Reichenbach S, Rutjes AW, Tschannen B, Altman DG, et al. Small study effects in meta-analyses of osteoarthritis trials: meta-epidemiological study. BMJ 2010;341:c3515.
74. Reeves BC, Deeks JJ, Higgins JPT, Wells GA. Chapter 13: Including non-randomized studies. In: Higgins JPT, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011.
75. Sandoval JA, Furlan AD, Mailis-Gagnon A. Oral methadone for chronic noncancer pain: a systematic literature review of reasons for administration, prescription patterns, effectiveness, and side effects. Clinical Journal of Pain 2005;21:503-12.
76. Shields LB, Hunsaker Iii JC, Corey TS, Ward MK, Stewart D. Methadone toxicity fatalities: a review of medical examiner cases in a large metropolitan area. Journal of Forensic Sciences 2007;52:1389-95.
77. Tsang A, Von Korff M, Lee S, Alonso J, Karam E, Angermeyer MC, et al. Common chronic pain conditions in developed and developing countries: gender and age differences and comorbidity with depression-anxiety disorders. Journal of Pain 2008;9:883-91.
78. Verhaak PF, Kerssens JJ, Dekker J, Sorbi MJ, Bensing JM. Prevalence of chronic benign pain disorder among adults: a review of the literature. Pain 1998;77:231-9.